Skip to main content

Want a detailed portfolio tracker?

Zenas Biopharma (ZBIO) P/E (2024 - 2026)

Zenas Biopharma (ZBIO) P/E from Sep 30, 2024 to Jul 21, 2026. The TTM Zenas Biopharma (ZBIO) P/E is -3.96. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Zenas Biopharma (ZBIO)

YearP/EChange
2026-3.96-16.28%
2025-4.73+26.06%
2024-3.75N/A

Comparison Zenas Biopharma (ZBIO) P/E with competitors

Zenas Biopharma (ZBIO) P/E is -3.96.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.04%
NBYStablecoin Development Corp0.00-100.11%
ENLVEnlivex Ltd0.07-101.89%
FGENFibroGen Inc0.24-106.06%
CHRSCoherus Biosciences Inc0.85-121.43%
FBIOFortress Biotech Inc0.95-123.97%
ORMPOramed Pharmaceuticals Inc1.50-137.96%
AGENAgenus Inc3.01-176.00%
INVAInnoviva Inc3.15-179.65%
VXRTVaxart Inc3.55-189.64%
CRMDCorMedix Inc3.63-191.63%
CVACCureVac N.V.4.45-212.26%
GLPGGalapagos NV4.86-222.70%
SRPTSarepta Therapeutics Inc4.88-223.28%
ABEOAbeona Therapeutics Inc5.39-236.05%
ABUSArbutus Biopharma Corp5.60-241.30%
ZVRAZevra Therapeutics Inc5.89-248.66%
SPROSpero Therapeutics Inc6.23-257.28%
CGENCompugen Ltd6.31-259.44%
RIGLRigel Pharmaceuticals6.87-273.53%
SLXNSilexion Therapeutics Corp7.30-284.24%
OMEROmeros Corporation9.26-333.80%
AUPHAurinia Pharmaceuticals Inc9.58-342.04%
PLXProtalix BioTherapeutics Inc10.89-375.02%
ACADAcadia Pharmaceuticals Inc11.73-396.17%
TBPHTheravance Biopharma Inc12.26-409.65%
ADMAAdma Biologics Inc12.42-413.58%
HRMYHarmony Biosciences Holdings Inc13.82-448.99%
SABSSAB Biotherapeutics Inc14.14-456.97%
NAGENiagen Bioscience Inc14.82-474.19%
INCYIncyte Corp15.82-499.55%
REGNRegeneron Pharmaceuticals Inc15.86-500.41%
PBYIPuma Biotechnology Inc17.32-537.26%
CPRXCatalyst Pharmaceuticals Inc17.44-540.38%
EXELExelixis Inc17.54-542.87%
TGTXTG Therapeutics Inc18.97-578.93%
MDXGMimedx Group Inc20.55-619.00%
XOMAXOMA Royalty Corp22.87-677.65%
ARGXArgen X SE24.30-713.59%
CTMXCytomX Therapeutics Inc24.82-726.80%
XOMAOXOMA Royalty Corp25.34-740.03%
HALOHalozyme Therapeutics Inc25.62-747.07%
XOMAPXOMA Royalty Corp25.67-748.24%
VRTXVertex Pharmaceuticals Inc27.99-806.95%
RPRXRoyalty Pharma plc - Class A28.69-824.44%
SLNOSoleno Therapeutics Inc29.02-832.72%
ASNDAscendis Pharma A/S30.09-859.75%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1057.39%
APLSApellis Pharmaceuticals Inc39.02-1085.40%
BMRNBiomarin Pharmaceutical Inc42.21-1165.97%
KRYSKrystal Biotech Inc45.34-1245.05%
ONCBeiGene Ltd69.54-1856.09%
PHARPharming Group N.V.75.03-1994.61%
TECHBio-Techne Corp101.96-2674.74%
VCELVericel Corp109.92-2875.83%
ALNYAlnylam Pharmaceuticals Inc117.96-3078.95%
GMABGenmab140.29-3642.74%
TLXTelix Pharmaceuticals Ltd162.15-4194.82%
CORTCorcept Therapeutics Inc212.86-5475.26%